{"AllianceGenome": "2634", "HGNC": "2634", "MIM": "601258", "_id": "1573", "_version": 1, "accession": {"genomic": ["AC113175.2", "AF039089.1", "AF272142.1", "AL445285.10", "AY426985.1", "CH471059.2", "CP068277.2", "KY933638.1", "KY933639.1", "KY933640.1", "KY933641.1", "NC_000001.11", "NC_060925.1", "NG_007931.2", "OQ434046.1", "OQ434054.1", "OQ434055.1"], "protein": ["AAC50370.2", "AAD30164.1", "AAH32594.1", "AAK63192.1", "AAM44456.1", "AAQ93356.1", "ATN24108.1", "ATN24109.1", "BAB85489.1", "BAG37780.1", "EAX06611.1", "EAX06612.1", "EAX06613.1", "EAX06614.1", "NP_000766.2", "P51589.2", "WEG22220.1", "WEG22228.1", "WEG22229.1", "XP_047303454.1", "XP_047303455.1", "XP_054190678.1", "XP_054190679.1"], "rna": ["AB080265.1", "AF144566.1", "AK055088.1", "AK315387.1", "BC032594.1", "BI457601.1", "CD013972.1", "CD013973.1", "NM_000775.4", "NR_134981.2", "NR_134982.2", "U37143.2", "XM_047447498.1", "XM_047447499.1", "XM_054334703.1", "XM_054334704.1"], "translation": [{"protein": "AAC50370.2", "rna": "U37143.2"}, {"protein": "XP_054190678.1", "rna": "XM_054334703.1"}, {"protein": "AAH32594.1", "rna": "BC032594.1"}, {"protein": "AAD30164.1", "rna": "AF144566.1"}, {"protein": "XP_047303454.1", "rna": "XM_047447498.1"}, {"protein": "NP_000766.2", "rna": "NM_000775.4"}, {"protein": "XP_047303455.1", "rna": "XM_047447499.1"}, {"protein": "BAG37780.1", "rna": "AK315387.1"}, {"protein": "BAB85489.1", "rna": "AB080265.1"}, {"protein": "XP_054190679.1", "rna": "XM_054334704.1"}]}, "alias": ["CPJ2", "CYPIIJ2"], "ec": ["1.14.14.73", "1.14.14.74", "5.4.4.7"], "ensembl": {"gene": "ENSG00000134716", "protein": ["ENSP00000360247", "ENSP00000497732", "ENSP00000497807", "ENSP00000498084"], "transcript": ["ENST00000371204", "ENST00000466095", "ENST00000468257", "ENST00000469406", "ENST00000492633"], "translation": [{"protein": "ENSP00000360247", "rna": "ENST00000371204"}, {"protein": "ENSP00000497732", "rna": "ENST00000469406"}, {"protein": "ENSP00000498084", "rna": "ENST00000466095"}, {"protein": "ENSP00000497807", "rna": "ENST00000468257"}], "type_of_gene": "protein_coding"}, "entrezgene": "1573", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 16.07816877, "exp_mis": 170.5445472, "exp_syn": 74.609738, "lof_z": -0.227731354942551, "mis_z": -0.316691848932708, "mu_lof": 1.08614951448e-06, "mu_mis": 1.47192963227e-05, "mu_syn": 6.25212391859e-06, "n_lof": 17.0, "n_mis": 179.0, "n_syn": 66.0, "p_li": 4.51201698997771e-12, "p_null": 0.97340826045585, "p_rec": 0.0265917395396382, "syn_z": 0.617933477429295}, "bp": 1509, "cds_end": 60392418, "cds_start": 60359322, "n_exons": 9, "nonpsych": {"exp_lof": 14.3665739, "exp_mis": 154.1735567, "exp_syn": 67.3432957, "lof_z": -0.164123717419786, "mis_z": -0.317920633553909, "mu_lof": 1.08614951448e-06, "mu_mis": 1.47192963227e-05, "mu_syn": 6.25212391859e-06, "n_lof": 15.0, "n_mis": 162.0, "n_syn": 58.0, "p_li": 1.33667829159604e-10, "p_null": 0.95179421318835, "p_rec": 0.0482057866779821, "syn_z": 0.716830693030598}, "nontcga": {"exp_lof": 14.77381294, "exp_mis": 156.8828921, "exp_syn": 68.6228625, "lof_z": -0.314696401438477, "mis_z": -0.243314573347002, "mu_lof": 1.08614951448e-06, "mu_mis": 1.47192963227e-05, "mu_syn": 6.25212391859e-06, "n_lof": 16.0, "n_mis": 163.0, "n_syn": 61.0, "p_li": 1.70336515084975e-11, "p_null": 0.969824546169603, "p_rec": 0.0301754538133633, "syn_z": 0.58264741640872}, "transcript": "ENST00000371204.3"}, "exons": [{"cdsend": 59926746, "cdsstart": 59893650, "chr": "1", "position": [[59893307, 59893829], [59900964, 59901103], [59904870, 59905058], [59907785, 59907927], [59909783, 59909960], [59911607, 59911768], [59912161, 59912311], [59915937, 59916100], [59926536, 59926773]], "strand": -1, "transcript": "NM_000775", "txend": 59926773, "txstart": 59893307}, {"cdsend": 59926798, "cdsstart": 59926798, "chr": "1", "position": [[59893307, 59893829], [59900964, 59901103], [59907785, 59907927], [59909783, 59909960], [59911607, 59911768], [59912161, 59912311], [59915937, 59916100], [59926536, 59926798]], "strand": -1, "transcript": "NR_134981", "txend": 59926798, "txstart": 59893307}, {"cdsend": 59926798, "cdsstart": 59926798, "chr": "1", "position": [[59893307, 59893829], [59900964, 59901103], [59904365, 59904516], [59904870, 59905058], [59907785, 59907927], [59909783, 59909960], [59911607, 59911768], [59912161, 59912311], [59915937, 59916100], [59926536, 59926798]], "strand": -1, "transcript": "NR_134982", "txend": 59926798, "txstart": 59893307}], "exons_hg19": [{"cdsend": 60392418, "cdsstart": 60359322, "chr": "1", "position": [[60358979, 60359501], [60366636, 60366775], [60370542, 60370730], [60373457, 60373599], [60375455, 60375632], [60377279, 60377440], [60377833, 60377983], [60381609, 60381772], [60392208, 60392445]], "strand": -1, "transcript": "NM_000775", "txend": 60392445, "txstart": 60358979}, {"cdsend": 60392470, "cdsstart": 60392470, "chr": "1", "position": [[60358979, 60359501], [60366636, 60366775], [60373457, 60373599], [60375455, 60375632], [60377279, 60377440], [60377833, 60377983], [60381609, 60381772], [60392208, 60392470]], "strand": -1, "transcript": "NR_134981", "txend": 60392470, "txstart": 60358979}, {"cdsend": 60392470, "cdsstart": 60392470, "chr": "1", "position": [[60358979, 60359501], [60366636, 60366775], [60370037, 60370188], [60370542, 60370730], [60373457, 60373599], [60375455, 60375632], [60377279, 60377440], [60377833, 60377983], [60381609, 60381772], [60392208, 60392470]], "strand": -1, "transcript": "NR_134982", "txend": 60392470, "txstart": 60358979}], "generif": [{"pubmed": 12386130, "text": "expression levels of the immunoreactive protein with the CYP2J2 antibody in the small intestine were well correlated with the activities of the astemizole O-demethylation"}, {"pubmed": 12737630, "text": "role of activator protein-1 in the down-regulation of the human CYP2J2 gene in hypoxia"}, {"pubmed": 14575523, "text": "Observational study of genotype prevalence and gene-disease association. (HuGE Navigator)"}, {"pubmed": 14575523, "text": "The CYP2J2*6 allele is rare in the Caucasian population, and no association is inferred between this allelic variant and type 1 or type 2 diabetic complications."}, {"pubmed": 15256482, "text": "Transgenic mice overexpressing human CYP2J2 have improved postischemic recovery of left ventricular function."}, {"pubmed": 15361551, "text": "Overexpressoin of CYP2J2 in transgenic mice increases l-type calcium channles in cardiomyocytes."}, {"pubmed": 15466638, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15466638, "text": "a functionally relevant polymorphism of the CYP2J2 gene is independently associated with an increased risk of coronary artery disease"}, {"pubmed": 15861034, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 15861034, "text": "characterization of novel CYP2J2 variants that cause loss of enzyme catalytic activity"}, {"pubmed": 15864120, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 15864120, "text": "there is an association between CYP2J2*7 (but not CYP2C8*3) genotype and hypertension in Caucasian males and Caucasians without a family history of hypertension"}, {"pubmed": 16008525, "text": "The c-Jun-responsive module between -122 and -50 in the CYP2J2 proximal promoter contains an atypical AP-1 element at -105/-95 that has a major role in c-Jun transactivation and acts in conjunction with the -56/-63 element to regulate expression."}, {"pubmed": 16182271, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 16202848, "text": "No association was found between any of the variant alleles and hypertension."}, {"pubmed": 16202848, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16842392, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16957870, "text": "comprehensive analysis of the distribution of sEH, CYP2C8, 2C9 and 2J2 in human neoplastic tissues using tissue micro-arrays"}, {"pubmed": 17126841, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 17126841, "text": "a CYP2J2*7 polymorphism may have a role in premature myocardial infarct"}, {"pubmed": 17162467, "text": "large inter-individual variation of the CYP2J2 suggests that this enzyme plays a significant role in the metabolism of xenobiotics"}, {"pubmed": 17286575, "text": "CYP2J2 gene is a susceptibility factor for essential hypertension, especially in females, and influences individual systolic blood pressure in the Chinese Han population"}, {"pubmed": 17286575, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17327508, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17429317, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 17429317, "text": "The G-50T polymorphism in CYP2J2 may be an important risk factor for the development of coronary heart disease events in African-Americans"}, {"pubmed": 17470359, "text": "These new selective inhibitors should be interesting tools to study the biological roles of CYP2J2."}, {"pubmed": 17475630, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17475630, "text": "Results indicate the CYP2J2 gene might be considered as a novel candidate gene for common susceptibility to asthma and highlight the importance of the P-450 epoxygenase pathway of metabolism of arachidonic acid in the pathogenesis of the disease."}, {"pubmed": 17638876, "text": "CYP2J2 has a role in cancer metastasis"}, {"pubmed": 17705402, "text": "The structural features that have been found to be important for recognition of substrates or inhibitors by CYP2J2 were also interpreted on the basis of CYP2J2-substrate interactions in this model."}, {"pubmed": 17979511, "text": "Genes encoding this enzyme modify cardiovascular disease risk at the population level in humans, providing support that modulation of this pathway may represent a novel approach to prevention. [REVIEW]"}, {"pubmed": 18004755, "text": "Flexible docking approaches were employed to dock 4 ligands into the active site of P450 2J2 to probe ligand-binding modes. Active site architecture and certain key residues responsible for substrate specificity were identified on the enzyme."}, {"pubmed": 18216721, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 18219097, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 18219097, "text": "a CYP2J2*7 allele of the CYP2J2 gene is clearly associated with an increased risk of essential hypertension."}, {"pubmed": 18303964, "text": "Clinical trial of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18496133, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18496133, "text": "Two intronic CYP2J2 tag-single nucleotide polymorphisms, rs10889160 and rs11572325 were associated with an increased risk of myocardial infarction. No evidence of an association was found between variation in CYP2J2 and stroke."}, {"pubmed": 18675280, "text": "These results suggest that expression of CYP2J2 was up-regulated when human monocytes differentiated into macrophages and that human monocytic cells and macrophages have a pathway to metabolize arachidonic acid using CYP epoxygenases."}, {"pubmed": 18729130, "text": "Genotype distribution of CYP2J2*7 polymorphisms was investigated using polymerase chain reaction and restriction fragment length polymorphism assay in Japanese, Mongolian and Ovambo populations and the findings compared with other populations."}, {"pubmed": 18729130, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 18769365, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18769365, "text": "This study examined the association between calcineurin inhibitors-induced nephrotoxicity in liver transplant patients and CYP2C8 and CYP2J2 polymorphisms."}, {"pubmed": 19105833, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19105833, "text": "among patients with high cardiovascular risk profile, carriers of the G-50T-promoter polymorphism have significantly more myocardial infarctions"}, {"pubmed": 19290787, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 19420105, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19448409, "text": "CYP epoxygenases efficiently promote the proliferation of tumor cells, which may be related with the activation of EGFR, ERK1/2 and PI3K/Akt signaling pathways."}, {"pubmed": 19550113, "text": "Data show that CYP2J2 is highly and selectively expressed in human tumor tissues and cell lines and may be a novel biomarker of human tumors."}, {"pubmed": 19576320, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19578796, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19615687, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19823578, "text": "CYP2J2 activates the nuclear receptor PPARalpha in vitro and in vivo"}, {"pubmed": 19851119, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19851119, "text": "data do not support a major role for the CYP2J2 -50G>T variant in determining blood pressure level and incident ischemic events"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19923256, "text": "eight novel substrates for CP2J were identified that vary in size and overall topology; data suggest that CYP2J2 may be an unrecognized participant in first-pass metabolism, but its contribution is minor relative to that of CYP3A4"}, {"pubmed": 20140850, "text": "Age of onset, family history, and obesity may modify typ3 2 diabetes polymorphism in younger onset typ32 diabetees."}, {"pubmed": 20173083, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 20379614, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20480811, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20480811, "text": "The data indicate that epoxygenase 2J2 gene polymorphism is not a risk factor of acute coronary syndrome in Ukrainian population."}, {"pubmed": 20597138, "text": "Haplotypes of CYP2J2 are associated with myocardial infarction in a Chinese Han population."}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 21030485, "text": "CYP2J2 overexpression in cultured human-derived malignant hematologic cell lines markedly accelerated proliferation and attenuated apoptosis"}, {"pubmed": 21059750, "text": "These data demonstrate that potentiation of the CYP epoxygenase pathway by either increased endothelial EET biosynthesis or globally decreased EET hydrolysis attenuates NF-kappaB-dependent vascular inflammatory responses in vivo."}, {"pubmed": 21642892, "text": "This case-control study as well as meta-analysis suggested no association between CYP2J2 G-50T and EPHX2 R287Q and the risk of developing coronary artery disease"}, {"pubmed": 22028915, "text": "monocytes and macrophages express the epoxygenases CYP2J2 and CYP2C8"}, {"pubmed": 22232929, "text": "No association has been found between the CYP2J2 (rs890293, -76G > T) or CYP2S1 (rs34971233, 13106C > T, P466L and rs338583, 13255A > G) gene polymorphisms and respiratory diseases."}, {"pubmed": 22731644, "text": "This study provides evidence of potential association of CYP2J2*7 polymorphism with hypertension in the Saudi population with or without diabetes and obesity."}, {"pubmed": 22761738, "text": "High CYP2J2 expression is associated with cancer."}, {"pubmed": 23155181, "text": "uteroplacental CYP2J2 overexpression contributes to preeclampsia."}, {"pubmed": 23474289, "text": "Established and emerging roles of CYP2J2 in the biology of vascular endothelial cells. [Review]"}, {"pubmed": 23647230, "text": "N404Y mutation could reposition the side-chain of Leu(378), making it no longer form a hydrogen bond with the carboxyl group of arachidonic acid."}, {"pubmed": 23661295, "text": "Compared the effects of N-terminal modifications on the properties of CYP2J2 with respect to the activity of the protein in model lipid bilayers using Nanodiscs."}, {"pubmed": 23684773, "text": "The aim of the present study was to assess the association between the human CYP2J2 gene polymorphism and coronary artery disease (CAD) in a Han and Uygur population of China."}, {"pubmed": 23696562, "text": "Data indicate that cardiac-specific overexpression of arachidonate epoxygenase (CYP2J2) significantly protects against diabetic cardiomyopathy, which may be due to improved cardiac insulin resistance, glucose uptake, and reversal of cardiac hypertrophy."}, {"pubmed": 23959307, "text": "CYP2J2 and CYP2C19 are the major liver microsomal enzymes responsible for biotransformation of albendazole and fenbendazole to produce active anthelmintics in vivo."}, {"pubmed": 24021950, "text": "CYP2J2 activity in the cell line was inhibited by danazol."}, {"pubmed": 24023684, "text": "CYP2J2 overexpression only moderately reduced transverse aortic constriction-induced cardiac hypertrophy and did not affect the hypertrophic response to beta-adrenergic stimulation."}, {"pubmed": 24058654, "text": "CYP2J2 mediates bacterial phagocytosis in macrophages, and implicates a defect in the CYP2J2 pathway may regulate bacterial clearance in Crohn's disease."}, {"pubmed": 24278032, "text": "These findings demonstrate that Cyp2j gene products regulate the pulmonary vascular response to hypoxia"}, {"pubmed": 25204827, "text": "findings can give a structural mechanism for the mutation-induced dysfunction in the CYP2J2-mediated arachidonic acid metabolism."}, {"pubmed": 25388680, "text": "Patients with CYP2C8*2C and EPHX2 404del variants had worse long-term outcomes while those with EPHX2 287Gln, CYP2J2*7, and CYP2C9 g.816G variants had favorable outcomes."}, {"pubmed": 25389363, "text": "Data suggest that up-regulation of CYP2J2 activity can attenuate type 2 diabetes and improve insulin resistance via down-regulation of NFkappaB and MAPK signaling pathways and up-regulation of PPARgamma."}, {"pubmed": 25406731, "text": "The present study shows that elevated EET levels in BC tissues are associated with upregulation of CYP2C8, 2C9, and 2J2, and downregulation of sEH, and are also associated with aggressive cell behavior in BC patients."}, {"pubmed": 25560582, "text": "Our results suggest that individuals with any conventional risk factor for MI along with CYP2J2*7 variant allele may be predisposed to risk of myocardial infarct in South Indian population"}, {"pubmed": 25601761, "text": "CYP2J2 expression showed significant upregulation (P<0.05) during Cy treatment before stem cell transplantation"}, {"pubmed": 25686540, "text": "CYP2J2 and EETs prevent cardiac fibrosis and cardiac dysfunction by suppressing transmission of pro-inflammation from cardiomyocytes to macrophages in heart"}, {"pubmed": 25796175, "text": "The CYP2J2 rs890293 T allele and GT+TT genotype were significantly associated with an increased risk of late onset Alzheimer disease."}, {"pubmed": 26209360, "text": "Tanshinone IIA exerts its anticancer effect by inhibiting CYP2J2 activity in HepG2 cells."}, {"pubmed": 26334592, "text": "Here we present the detection of substrate binding to cytochrome P450-2J2 (CYP2J2), the predominant P450 in the human heart, using a combination of Nanodisc technology and a nanohole plasmonic sensor"}, {"pubmed": 26972388, "text": "Data suggest that antiarrhythmic prodrugs amiodarone and dronedarone are extensively metabolized by CYP2J2; specific CYP2J2 metabolites include N-desbutyldronedarone and N-desethylamiodarone, potent [reversible/irreversible] inhibitors of CYP2J2."}, {"pubmed": 27286171, "text": "CYP2J2 is widely expressed in tissues, especially heart, vascular smooth muscle, salivary glands and placenta. Recent studies have shown that overexpression of CYP2J2 in vivo reverses several pathological processes in animals, including hypertension and other cardiovascular pathologies and insulin resistance."}, {"pubmed": 27396818, "text": "Study found a significant interaction between CYP2J2- rs890293 and PPAR -gamma- rs1805192 and participants with GT or TT of rs890293 and CG or GG of rs1805192 genotype have the highest late-onset Alzheimer's disease risk, compared to participants with GG of rs890293 and CC of rs1805192 genotype."}, {"pubmed": 27401401, "text": "dysregulation of the CYP epoxyeicosanoid pathway is a key pathological consequence of NASH"}, {"pubmed": 27459385, "text": "Data show that CYP2J2 gene delivery reduced vessel wall thickening."}, {"pubmed": 27796781, "text": "a computational investigation of the binding of arachidonic acid (AA) to CYP2J2 using homology modelling, induced fit docking (IFD) and molecular dynamics (MD) simulations."}, {"pubmed": 28030819, "text": "Homocysteine (Hcy) facilitated cytochrome P-450 CYP2J2 (CYP2J2) upregulation in hepatocellular carcinoma (HCC) cells by DNA demethylation."}, {"pubmed": 28237619, "text": "MAPK signaling pathway was involved in the up-regulation of CYP2J2 levels by glutamate in U251 cells."}, {"pubmed": 28272236, "text": "-50G/T polymorphism might be a risk factor for ischemic stroke in Chinese population"}, {"pubmed": 28328948, "text": "Endothelial overexpression of CYP2J2 significantly changed oxylipin profiles."}, {"pubmed": 28374982, "text": "Angiotensin II receptor blockers exhibit different degrees of inhibition of the metabolism of arachidonic acid by recombinant CYP2C9, CYP2J2 and liver microsomes."}, {"pubmed": 28461575, "text": "The use of LKY-047 as a selective CYP2J2 inhibitor."}, {"pubmed": 29022765, "text": "Single Nucleotide Polymorphism in CYP2J2, which synthesize epoxyeicosatrienoic acids, may modify Cardiovascular outcomes in Renal Transplant recipients."}, {"pubmed": 29046152, "text": "CYP2J2 50 G>T polymorphism is associated with increased risk of cerebral small vessel disease in Han Chinese."}, {"pubmed": 29200270, "text": "demonstrate that doxorubicin (DOX) and 7-de-aDOX inhibit CYP2J2-mediated AA metabolism and 7-de-aDOX binds close to the active site to alter the ratio of cardioprotective epoxyeicosatrienoic acids."}, {"pubmed": 29343610, "text": "Cell survival decreases with ROS exposure when CYP2J2 is chemically inhibited."}, {"pubmed": 29580941, "text": "Increased epoxyeicosatrienoic acids may be part of a protective mechanism in human ulcerative colitis, with increased CYP2J2 and reduced soluble epoxide hydrolase expression."}, {"pubmed": 29629756, "text": "these data can aid the design of other analogues that have reduced cardiotoxicity, which do not modulate CYP2J2's arachidonic acid metabolism."}, {"pubmed": 29908721, "text": "In the villous trophoblast, CYP2C8 was the most abundant protein. Its expression is higher than the CYP2C9 and CYP2J2 in the cytotrophoblast in the embryonic stage of development and remains higher in syncytiotrophoblast of term placenta."}, {"pubmed": 30012976, "text": "Data show the importance of the formation of a hydrogen bond between cytochrome P450 2J2 arginine 117 (R117) and the keto group of the substrates."}, {"pubmed": 30019995, "text": "There were 15 genetic variants identified in CYP2J2 genes in three Chinese populations: Han, Tibetan and Uighur."}, {"pubmed": 30219518, "text": "Our findings demonstrate that CYP2J2 improves cardiac function by increasing the concentration of circulating EETs, and boosting angiogenesis via the Jagged1/Notch1 signaling pathway in MI-induced heart failure."}, {"pubmed": 30518987, "text": "In conclusion, the rs2280275 and rs11572325 SNPs of CYP2J2 may be considered novel genetic markers of hypertension, at least in Russian women"}, {"pubmed": 30861250, "text": "Studies report on the role of the surrounding lipid environment and macromolecular crowding in modulating enzymatic function of CYP2J2-cytochrome P450 reductase membrane protein system."}, {"pubmed": 31000184, "text": "A functionally relevant polymorphism of the CYP2J2 gene was independently associated with an increased risk of CAD."}, {"pubmed": 31622444, "text": "The CYP2J2*7 SNP in the donor was associated with elevated risk of delayed graft function."}, {"pubmed": 31902555, "text": "CYP2J2 50G>T (rs890293) polymorphism was associated with an increased risk for psoriasis in the Turkish population"}, {"pubmed": 32210298, "text": "CYP2J2 Modulates Diverse Transcriptional Programs in Adult Human Cardiomyocytes."}, {"pubmed": 32224017, "text": "Influence of the CYP2J2 Gene Polymorphisms on Chronic Obstructive Pulmonary Disease Risk in the Chinese Han Population."}, {"pubmed": 33312341, "text": "6,8-Diprenylorobol Induces Apoptosis in Human Hepatocellular Carcinoma Cells via Activation of FOXO3 and Inhibition of CYP2J2."}, {"pubmed": 33335233, "text": "Molecular determinant of substrate binding and specificity of cytochrome P450 2J2."}, {"pubmed": 34258261, "text": "CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma."}, {"pubmed": 34774051, "text": "CYP2J2 and EETs protect against pulmonary arterial hypertension with lung ischemia-reperfusion injury in vivo and in vitro."}, {"pubmed": 36269280, "text": "Endothelial CYP2J2 overexpression restores the BRB via METTL3-mediated ANXA1 upregulation."}, {"pubmed": 36587509, "text": "CYP2C8 and CYP2J2 gene variations increase the risk of hypertensive intracerebral hemorrhage."}], "genomic_pos": {"chr": "1", "end": 59926773, "ensemblgene": "ENSG00000134716", "start": 59893308, "strand": -1}, "genomic_pos_hg19": {"chr": "1", "end": 60392462, "start": 60358980, "strand": -1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0006082", "qualifier": "involved_in", "term": "organic acid metabolic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006631", "qualifier": "involved_in", "term": "fatty acid metabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006690", "pubmed": 19737933, "qualifier": "involved_in", "term": "icosanoid metabolic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006805", "qualifier": "involved_in", "term": "xenobiotic metabolic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006805", "pubmed": 11901223, "qualifier": "involved_in", "term": "xenobiotic metabolic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0008016", "pubmed": 8631948, "qualifier": "involved_in", "term": "regulation of heart contraction"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0019373", "pubmed": [8631948, 11901223], "qualifier": "involved_in", "term": "epoxygenase P450 pathway"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0019373", "qualifier": "involved_in", "term": "epoxygenase P450 pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0043651", "pubmed": 11901223, "qualifier": "involved_in", "term": "linoleic acid metabolic process"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005789", "qualifier": "located_in", "term": "endoplasmic reticulum membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0043231", "qualifier": "is_active_in", "term": "intracellular membrane-bounded organelle"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0070062", "pubmed": 18570454, "qualifier": "located_in", "term": "extracellular exosome"}], "MF": [{"category": "MF", "evidence": "TAS", "id": "GO:0004497", "qualifier": "enables", "term": "monooxygenase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0005506", "qualifier": "enables", "term": "iron ion binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008392", "pubmed": [8631948, 11901223], "qualifier": "enables", "term": "arachidonic acid epoxygenase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0008392", "qualifier": "enables", "term": "arachidonic acid epoxygenase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008404", "pubmed": 11901223, "qualifier": "enables", "term": "arachidonic acid 14,15-epoxygenase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008405", "pubmed": 11901223, "qualifier": "enables", "term": "arachidonic acid 11,12-epoxygenase activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0016712", "qualifier": "enables", "term": "oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen"}, {"category": "MF", "evidence": "IDA", "id": "GO:0016853", "pubmed": 19737933, "qualifier": "enables", "term": "isomerase activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0020037", "qualifier": "enables", "term": "heme binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0071614", "pubmed": 11901223, "qualifier": "enables", "term": "linoleic acid epoxygenase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0106255", "qualifier": "enables", "term": "hydroperoxy icosatetraenoate isomerase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0106301", "qualifier": "enables", "term": "arachidonic acid 5,6-epoxygenase activity"}]}, "homologene": {"genes": [[6239, 173787], [6239, 178695], [6239, 178704], [6239, 178706], [6239, 178752], [6239, 178926], [6239, 179148], [6239, 182888], [6239, 183484], [6239, 183602], [6239, 185589], [6239, 185591], [6239, 185653], [6239, 187025], [6239, 187183], [6239, 187184], [6239, 187185], [6239, 187573], [6239, 187705], [6239, 189364], [6239, 189444], [6239, 190065], [6239, 3565571], [7165, 1268425], [7165, 1276340], [7165, 1276343], [7165, 3290015], [7165, 4397850], [7227, 40161], [7955, 259306], [7955, 393108], [7955, 393592], [7955, 399485], [7955, 492484], [7955, 494153], [7955, 569245], [7955, 797309], [7955, 799957], [7955, 100034366], [7955, 100034406], [8364, 100492305], [9031, 424729], [9544, 693631], [9598, 456896], [9606, 1573], [9615, 610195], [9913, 510406], [9913, 511936], [9913, 521656], [9913, 530929], [10090, 13110], [10116, 65210]], "id": 68091}, "interpro": [{"desc": "Cytochrome P450", "id": "IPR001128", "short_desc": "Cyt_P450"}, {"desc": "Cytochrome P450, E-class, group I", "id": "IPR002401", "short_desc": "Cyt_P450_E_grp-I"}, {"desc": "Cytochrome P450, E-class, group I, CYP2J-like", "id": "IPR008071", "short_desc": "Cyt_P450_E_grp-I_CYP2J-like"}, {"desc": "Cytochrome P450, conserved site", "id": "IPR017972", "short_desc": "Cyt_P450_CS"}, {"desc": "Cytochrome P450 superfamily", "id": "IPR036396", "short_desc": "Cyt_P450_sf"}], "ipi": "IPI00019411", "map_location": "1p32.1", "name": "cytochrome P450 family 2 subfamily J member 2", "other_names": ["albendazole monooxygenase (hydroxylating)", "albendazole monooxygenase (sulfoxide-forming)", "arachidonic acid epoxygenase", "cytochrome P450 2J2", "cytochrome P450, family 2, subfamily J, polypeptide 2", "cytochrome P450, subfamily IIJ (arachidonic acid epoxygenase) polypeptide 2", "flavoprotein-linked monooxygenase", "hydroperoxy icosatetraenoate isomerase", "microsomal monooxygenase"], "pantherdb": {"HGNC": "2634", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "2449816", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 10090, "uniprot_kb": "A0A140T8U1"}, {"MGI": "2449817", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 10090, "uniprot_kb": "G3UZ38"}, {"MGI": "2140224", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 10090, "uniprot_kb": "Q3UNV2"}, {"RGD": "1561242", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 10116, "uniprot_kb": "A0A0G2JTQ9"}, {"MGI": "2385197", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 10090, "uniprot_kb": "Q3UNV4"}, {"MGI": "1921769", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 10090, "uniprot_kb": "Q924D1"}, {"RGD": "631442", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 10116, "uniprot_kb": "P51590"}, {"MGI": "3717097", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 10090, "uniprot_kb": "G3UXT0"}, {"RGD": "1563215", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 10116, "uniprot_kb": "E9PSJ0"}, {"MGI": "1270149", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 10090, "uniprot_kb": "O54749"}, {"MGI": "1270148", "ortholog_type": "LDO", "panther_family": "PTHR24300", "taxid": 10090, "uniprot_kb": "O54750"}, {"RGD": "620007", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 10116, "uniprot_kb": "F7FF10"}, {"Gene": "CYP2J4", "ortholog_type": "LDO", "panther_family": "PTHR24300", "taxid": 10116, "uniprot_kb": "Q9QXF7"}, {"Ensembl": "ENSGALG00000052676", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 9031, "uniprot_kb": "A0A1L1RRG6"}, {"Ensembl": "ENSGALG00000011413", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 9031, "uniprot_kb": "E1BVV4"}, {"Ensembl": "ENSGALG00000011394", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 9031, "uniprot_kb": "A0A1D5PYA5"}, {"Ensembl": "ENSGALG00000051992", "ortholog_type": "LDO", "panther_family": "PTHR24300", "taxid": 9031, "uniprot_kb": "A0A1L1RVS8"}, {"Ensembl": "ENSDARG00000110311", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "A0A2R8QE14"}, {"ZFIN": "ZDB-GENE-060818-12", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "A0PGL6"}, {"Ensembl": "ENSDARG00000116677", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "A0A2R8S079"}, {"ZFIN": "ZDB-GENE-040704-28", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "A0A2R8QED6"}, {"Ensembl": "ENSDARG00000114326", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "A0A2R8QN55"}, {"ZFIN": "ZDB-GENE-161014-2", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "A0A2R8RJY4"}, {"ZFIN": "ZDB-GENE-110114-2", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "A0A2R8QAB9"}, {"ZFIN": "ZDB-GENE-030131-4664", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "A0A1L1QZC0"}, {"ZFIN": "ZDB-GENE-050320-144", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "F1QSL5"}, {"ZFIN": "ZDB-GENE-061027-109", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "F1QYD1"}, {"ZFIN": "ZDB-GENE-080724-3", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "A0A0R4IV56"}, {"ZFIN": "ZDB-GENE-041010-183", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "A0A0R4IP03"}, {"ZFIN": "ZDB-GENE-031030-8", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "B3DJ50"}, {"ZFIN": "ZDB-GENE-040625-72", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "A0A0R4II65"}, {"ZFIN": "ZDB-GENE-070424-33", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "A0A0R4IHQ7"}, {"ZFIN": "ZDB-GENE-071004-47", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "A0A0R4IQ46"}, {"ZFIN": "ZDB-GENE-110114-3", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "A0A0R4ISJ6"}, {"ZFIN": "ZDB-GENE-061027-232", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "F1Q7C7"}, {"ZFIN": "ZDB-GENE-071004-48", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "A0A0R4IFF1"}, {"ZFIN": "ZDB-GENE-061030-1", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "Q5TZ86"}, {"ZFIN": "ZDB-GENE-041210-324", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "Q5RG51"}, {"ZFIN": "ZDB-GENE-040120-2", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "Q5TZ85"}, {"ZFIN": "ZDB-GENE-040426-790", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "Q5TZ76"}, {"ZFIN": "ZDB-GENE-041001-155", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "E7FEJ8"}, {"ZFIN": "ZDB-GENE-040120-1", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "Q5TZ84"}, {"ZFIN": "ZDB-GENE-020812-2", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "Q98T96"}, {"ZFIN": "ZDB-GENE-041001-156", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "Q5TZ78"}, {"Ensembl": "ENSDARG00000110366", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "A0A2R8Q5Q6"}, {"ZFIN": "ZDB-GENE-041001-157", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "Q5TZ81"}, {"ZFIN": "ZDB-GENE-040912-139", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "Q66I26"}, {"ZFIN": "ZDB-GENE-090312-107", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "E7FGY5"}, {"ZFIN": "ZDB-GENE-041001-158", "ortholog_type": "LDO", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "Q5TZ82"}, {"dictyBase": "DDB_G0272704", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 352472, "uniprot_kb": "Q86A22"}, {"dictyBase": "DDB_G0286743", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 352472, "uniprot_kb": "Q54LA8"}, {"dictyBase": "DDB_G0282769", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 352472, "uniprot_kb": "Q1ZXG3"}, {"dictyBase": "DDB_G0282283", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 352472, "uniprot_kb": "Q54SV9"}], "uniprot_kb": "P51589"}, "pathway": {"biocarta": {"id": "eicosanoidpathway", "name": "eicosanoid metabolism"}, "kegg": [{"id": "hsa00590", "name": "Arachidonic acid metabolism - Homo sapiens (human)"}, {"id": "hsa00591", "name": "Linoleic acid metabolism - Homo sapiens (human)"}, {"id": "hsa04726", "name": "Serotonergic synapse - Homo sapiens (human)"}, {"id": "hsa04750", "name": "Inflammatory mediator regulation of TRP channels - Homo sapiens (human)"}, {"id": "hsa04913", "name": "Ovarian steroidogenesis - Homo sapiens (human)"}, {"id": "hsa05417", "name": "Lipid and atherosclerosis - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-211859", "name": "Biological oxidations"}, {"id": "R-HSA-211897", "name": "Cytochrome P450 - arranged by substrate type"}, {"id": "R-HSA-211935", "name": "Fatty acids"}, {"id": "R-HSA-211945", "name": "Phase I - Functionalization of compounds"}, {"id": "R-HSA-211981", "name": "Xenobiotics"}, {"id": "R-HSA-2142670", "name": "Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)"}, {"id": "R-HSA-2142753", "name": "Arachidonic acid metabolism"}, {"id": "R-HSA-556833", "name": "Metabolism of lipids"}, {"id": "R-HSA-8978868", "name": "Fatty acid metabolism"}], "smpdb": [{"id": "SMP00075", "name": "Arachidonic Acid Metabolism"}, {"id": "SMP00077", "name": "Piroxicam Action Pathway"}, {"id": "SMP00083", "name": "Acetylsalicylic Acid Action Pathway"}, {"id": "SMP00084", "name": "Etodolac Action Pathway"}, {"id": "SMP00085", "name": "Ketoprofen Action Pathway"}, {"id": "SMP00086", "name": "Ibuprofen Action Pathway"}, {"id": "SMP00087", "name": "Rofecoxib Action Pathway"}, {"id": "SMP00093", "name": "Diclofenac Action Pathway"}, {"id": "SMP00094", "name": "Sulindac Action Pathway"}, {"id": "SMP00096", "name": "Celecoxib Action Pathway"}, {"id": "SMP00098", "name": "Ketorolac Action Pathway"}, {"id": "SMP00101", "name": "Suprofen Action Pathway"}, {"id": "SMP00102", "name": "Bromfenac Action Pathway"}, {"id": "SMP00104", "name": "Indomethacin Action Pathway"}, {"id": "SMP00106", "name": "Meloxicam Action Pathway"}, {"id": "SMP00109", "name": "Mefenamic Acid Action Pathway"}, {"id": "SMP00113", "name": "Oxaprozin Action Pathway"}, {"id": "SMP00114", "name": "Nabumetone Action Pathway"}, {"id": "SMP00116", "name": "Valdecoxib Action Pathway"}, {"id": "SMP00120", "name": "Naproxen Action Pathway"}, {"id": "SMP00289", "name": "Diflunisal Action Pathway"}, {"id": "SMP00353", "name": "Leukotriene C4 Synthesis Deficiency"}, {"id": "SMP00692", "name": "Antipyrine Action Pathway"}, {"id": "SMP00693", "name": "Antrafenine Action Pathway"}, {"id": "SMP00694", "name": "Carprofen Action Pathway"}, {"id": "SMP00695", "name": "Etoricoxib Action Pathway"}, {"id": "SMP00696", "name": "Fenoprofen Action Pathway"}, {"id": "SMP00697", "name": "Flurbiprofen Action Pathway"}, {"id": "SMP00698", "name": "Magnesium salicylate Action Pathway"}, {"id": "SMP00699", "name": "Lumiracoxib Action Pathway"}, {"id": "SMP00700", "name": "Lornoxicam Action Pathway"}, {"id": "SMP00701", "name": "Phenylbutazone Action Pathway"}, {"id": "SMP00702", "name": "Nepafenac Action Pathway"}, {"id": "SMP00703", "name": "Trisalicylate-choline Action Pathway"}, {"id": "SMP00704", "name": "Tolmetin Action Pathway"}, {"id": "SMP00705", "name": "Tiaprofenic Acid Action Pathway"}, {"id": "SMP00706", "name": "Tenoxicam Action Pathway"}, {"id": "SMP00707", "name": "Salsalate Action Pathway"}, {"id": "SMP00708", "name": "Salicylate-sodium Action Pathway"}, {"id": "SMP00709", "name": "Salicylic Acid Action Pathway"}, {"id": "SMP00710", "name": "Acetaminophen  Action Pathway"}], "wikipathways": [{"id": "WP43", "name": "Oxidation by Cytochrome P450"}, {"id": "WP465", "name": "Tryptophan metabolism"}, {"id": "WP678", "name": "Arachidonate Epoxygenase - Epoxide Hydrolase"}, {"id": "WP702", "name": "Metapathway biotransformation Phase I and II"}]}, "pfam": "PF00067", "pharmgkb": "PA27112", "pharos": {"target_id": 6926, "tdl": "Tchem"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF248207", "relationship": "is"}, {"id": "GNF248208", "relationship": "is"}, {"id": "GNF248209", "relationship": "is"}, {"id": "GNF248210", "relationship": "is"}, {"id": "GNF272855", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF164824", "relationship": "weakly similar to"}, "GNF_hs-Origene": {"id": "GNF032602", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF081536", "relationship": "is"}, {"id": "GNF081537", "relationship": "is"}, {"id": "GNF081538", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF051659", "relationship": "is"}, {"id": "GNF056425", "relationship": "is"}, {"id": "GNF061183", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF065961", "relationship": "is"}, {"id": "GNF065962", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF003242", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF094045", "relationship": "is"}, {"id": "GNF133703", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000001.11", "NC_060925.1", "NG_007931.2"], "protein": ["NP_000766.2", "XP_047303454.1", "XP_047303455.1", "XP_054190678.1", "XP_054190679.1"], "rna": ["NM_000775.4", "NR_134981.2", "NR_134982.2", "XM_047447498.1", "XM_047447499.1", "XM_054334703.1", "XM_054334704.1"], "translation": [{"protein": "XP_054190678.1", "rna": "XM_054334703.1"}, {"protein": "XP_047303454.1", "rna": "XM_047447498.1"}, {"protein": "NP_000766.2", "rna": "NM_000775.4"}, {"protein": "XP_047303455.1", "rna": "XM_047447499.1"}, {"protein": "XP_054190679.1", "rna": "XM_054334704.1"}]}, "reporter": {"HG-U133_Plus_2": "205073_at", "HG-U95Av2": ["500_at", "501_g_at"], "HTA-2_0": "TC01002717.hg.1", "HuEx-1_0": "2415266", "HuGene-1_1": "7916616", "HuGene-2_1": "16687914"}, "summary": "This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is thought to be the predominant enzyme responsible for epoxidation of endogenous arachidonic acid in cardiac tissue. Multiple transcript variants have been found for this gene. [provided by RefSeq, Jan 2016].", "symbol": "CYP2J2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1413880"}, "unigene": "Hs.152096", "uniprot": {"Swiss-Prot": "P51589", "TrEMBL": ["A0A3B3IU95", "A0A3B3IT99", "A0A3B3ITF2"]}, "wikipedia": {"url_stub": "CYP2J2"}}